A4P provides consultancy and project management services in appraising the intended biomarker analytes, evaluating them
for their clinical use and utility and managing the generation of relevant analytical data.

A4P’s consultancy services in this critically important area are built on a significant body of experience from across numerous
therapeutic areas. Our expertise covers from transition of early phase experimental biomarkers through to efficacy markers used in diagnostics.

A4P project management of biomarkers from clinical studies mainly focusses on the generation and interpretation of quantitative data.

A4P manages this through by:

• Reviews of bioanalytical reports, project and product assay summaries and regulatory documentation.
• A4P solutions are built for each individual client’s requirements.
  Our outputs are supported by quality documented procedures and processes, all of which can be customised to individual clients needs whilst ensuring compliance with the latest regulatory requirements.